We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Liver Surgery Boosts Bowel Cancer Survival Rate

By HospiMedica International staff writers
Posted on 16 Jun 2010
A new study shows that liver resection in patients with stage IV bowel cancer can boost five-year survival rate by almost 46%. More...


Researchers of the United Kingdom National Cancer Intelligence Network (NCIN; London) conducted a population-based study that followed 114,155 patients identified via the National Cancer Data Repository who underwent surgery for colorectal cancer between January 1998 and June 2004, of whom 3,116 (2.7%) subsequently had one or more hepatic resections; the hepatectomy rate increased from 1.7% in 1998 to 3.8% in 2004. All episodes of care in the 3 years after the initial operation were examined to determine the frequency of liver resection, and variations in the use of liver resection and survival were assessed.

The researchers found there was significant variation in the rate of liver resection across cancer networks and hospitals; the crude 5-year survival rate after liver resection was 44.2% from the time of hepatectomy and 45.9% from the time of colectomy. This was comparable to the 5-year survival rate of patients with stage III disease (42.2%). The study was published online on June 2, 2010, in the British Journal of Surgery.

"This surgery is very skilled and should be undertaken by expert surgeons working in specialist liver units,” said lead author Eva Morris, M.D., of the University of Leeds (United Kingdom). "We must work towards ensuring that all patients who need liver resections can access these services.”

Although first performed in 1943, the liver resection technique only became accepted practice in the mid 1990's, as initially it was very high-risk surgery. It ultimately became the gold standard treatment for bowel cancer that has spread to the liver in 2004.

Related Links:

United Kingdom National Cancer Intelligence Network
University of Leeds



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.